A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. [electronic resource]
Producer: 20021001Description: 491-6 p. digitalISSN:- 0007-0920
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Hematologic Diseases -- chemically induced
- Humans
- Life Tables
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Neoplasm Staging
- Pleural Neoplasms -- drug therapy
- Quality of Life
- Respiratory Function Tests
- Survival Analysis
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.